Sign Out
Posology: Primary vaccination: The primary vaccination schedule consists of 3 injections of one reconstituted dose (0.5 mL) to be administered at 6 month intervals.
If flexibility in the vaccination schedule is necessary, a time window of +/- 20 days is acceptable (see Pharmacology: Pharmacodynamics under Actions).
Dengvaxia should not be administered in individuals less than 9 years of age.
Booster dose: The need for a booster dose after primary vaccination with Dengvaxia has not been established.
Method of administration: Once the freeze-dried vaccine has been completely reconstituted using the solvent provided, it is administered by subcutaneous (SC) injection. The recommended injection site is the deltoid region.
Precautions to be taken before handling or administering the medicinal product: Do not administer by intravascular injection.
Dengvaxia must not be mixed with any other injectable vaccine(s) or medicinal product(s).
For instructions on reconstitution of Dengvaxia before administration, see Special precautions for disposal and other handling under Cautions for Usage.
